Pediatric adverse reactions to antiseizure medications - An analysis of data from the Italian spontaneous reporting system (2001-2019)

被引:14
|
作者
Franco, Valentina [1 ,2 ]
Barbieri, Maria Antonietta [3 ]
Cutroneo, Paola Maria [4 ]
Arena, Ignazio [3 ]
Cicala, Giuseppe [3 ]
Marchione, Pasquale [5 ]
Spina, Edoardo [3 ]
Perucca, Emilio [1 ]
机构
[1] Univ Pavia, Dept Internal Med & Therapeut, Div Clin & Expt Pharmacol, Pavia, Italy
[2] IRCCS Mondino Fdn, Pavia, Italy
[3] Univ Messina, Dept Clin & Expt Med, Messina, Italy
[4] Univ Hosp Messina, Sicilian Reg Pharmacovigilance Ctr, Messina, Italy
[5] Italian Med Agcy, Signal Management Unit, Rome, Italy
关键词
Drug surveillance; Adverse drug reactions; Pediatric; Antiepileptic drugs; ANTIEPILEPTIC DRUGS; EPILEPSY; CHILDREN; POPULATION; TOPIRAMATE; MEDICINES; CHILDHOOD;
D O I
10.1016/j.yebeh.2021.107989
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Introduction: Spontaneous reports of adverse drug reactions (ADRs) are a valuable supplement to clinical studies in informing about the safety of medications. This is especially relevant for pediatric populations, which are not often included in large-scale clinical trials. Objectives: To evaluate patterns of pediatric ADRs to antiseizure medications (ASMs) reported to the Italian Spontaneous Reporting System (SRS) database during the period November 1, 2001-May 31, 2019. Methods: Suspected ADRs ascribed to medications listed under ATC code N03, plus clobazam (code N05BA09), and affecting individuals below age 18 years were sourced from the Italian SRS database, categorized based on a modification of the MedDRA (R) high-level term, and analyzed using descriptive statistics. Results: A total of 956 reports listing a total of 1806 ADRs ascribed to one or more ASMs were received for individuals in pediatric age. The most commonly reported ADRs were skin rashes (24.0% of all reports), epileptic seizures (12.6%), gastrointestinal disturbances (11.8%), and somnolence (10.6%). A more detailed analysis was conducted on 675 reports listing a single ASM as suspected drug and occurring in patients with a specified or presumed diagnosis of epilepsy. Adverse drug reaction patterns differed widely across ASMs. Skin rashes were the most commonly reported ADR for lamotrigine (62.3%), carbamazepine (50.3%), phenobarbital (42.3%), and oxcarbazepine (33.0%). Other most commonly reported ADRs were gastrointestinal symptoms for ethosuximide (44%), irritability/aggression for levetiracetam (25.0%), epileptic seizures for valproic acid (16.1%), fever (often associated with hypohidrosis) for topiramate (17.9%), and utilization error (mostly accidental drug administration) for clonazepam (34.6%). Conclusions: Patterns of spontaneous ADR reports are indicative of major differences in safety profile among individual ASMs. Most, but not all, frequently reported ADRs were in line with findings from clinical trials and observational studies. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页数:7
相关论文
共 50 条
  • [12] Ocular Adverse Events Following Immunization (AEFI): Data From the Italian Spontaneous Reporting System
    Moretti, U.
    Zanoni, G.
    Lora, R.
    Opri, R.
    Tartaglia, L.
    Trotta, F.
    Ferrazin, F.
    Santuccio, C.
    DRUG SAFETY, 2012, 35 (10) : 961 - 962
  • [13] Suspected Adverse Drug Reactions in Children: A Descriptive Study of the Italian Spontaneous Reporting System
    Ferrajolo, C.
    Capuano, A.
    Rossi, F.
    Moretti, U.
    Trifiro, G.
    Santuccio, C.
    DRUG SAFETY, 2013, 36 (09) : 882 - 882
  • [14] Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database
    Barbieri, Maria Antonietta
    Cutroneo, Paola Maria
    Baratelli, Chiara
    Cicala, Giuseppe
    Battaglia, Alessandro
    Santoro, Vincenza
    Ando, Giuseppe
    Spina, Edoardo
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (04) : 1027 - 1040
  • [15] Cutaneous Drug Reactions: Data from an Italian Spontaneous Reporting Database
    Leone, R.
    Magro, L.
    Moretti, U.
    Donati, M.
    Cutroneo, P.
    Moschini, M.
    Motola, D.
    Tuccori, M.
    Cocci, A.
    Conforti, A.
    DRUG SAFETY, 2009, 32 (10) : 955 - 955
  • [16] Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Emily E. Leppien
    Bennett J. Doughty
    Karyssa L. Hurd
    Keira N. Strong
    Brian J. Piper
    Kenneth L. McCall
    Clinical Drug Investigation, 2023, 43 : 393 - 399
  • [17] Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Leppien, Emily E.
    Doughty, Bennett J.
    Hurd, Karyssa L.
    Strong, Keira N.
    Piper, Brian J.
    McCall, Kenneth L.
    CLINICAL DRUG INVESTIGATION, 2023, 43 (06) : 393 - 399
  • [18] Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database
    Barbieri, Maria Antonietta
    Cicala, Giuseppe
    Cutroneo, Paola Maria
    Mocciaro, Eleonora
    Sottosanti, Laura
    Freni, Francesco
    Galletti, Francesco
    Arcoraci, Vincenzo
    Spina, Edoardo
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [19] Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System
    Crisafulli, Salvatore
    Cutroneo, Paola Maria
    Luxi, Nicoletta
    Fontana, Andrea
    Ferrajolo, Carmen
    Marchione, Pasquale
    Sottosanti, Laura
    Zanoni, Giovanna
    Moretti, Ugo
    Franze, Silvia
    Minghetti, Paola
    Trifiro, Gianluca
    DRUG SAFETY, 2023, 46 (04) : 343 - 355
  • [20] Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System
    Salvatore Crisafulli
    Paola Maria Cutroneo
    Nicoletta Luxi
    Andrea Fontana
    Carmen Ferrajolo
    Pasquale Marchione
    Laura Sottosanti
    Giovanna Zanoni
    Ugo Moretti
    Silvia Franzè
    Paola Minghetti
    Gianluca Trifirò
    Drug Safety, 2023, 46 : 343 - 355